I remember you saying you thought the buyout # was somewhere between $1.5 bil-$2 bil. That would be wonderful for the shareholders and especially for the people who need the drugs (A big pharma like Mrk or Nvs could surely get them to market faster than Aria). I just don't see Berger selling Ariad. This is his life's work and I think he wants to see the finish line. My feeling is that any takeover would have to be hostile because the asking price would prob be too high.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.